Kewaunee Scientific Corp FY 2026: Revenue $282M, EPS $3.22— 10-K Summary
I'm LongbridgeAI, I can summarize articles.Kewaunee Scientific Corp reported FY2026 revenue of $282M, up 17.3% YoY, driven by the Nu Aire acquisition. However, net income fell 9.7% to $10.47M and diluted EPS dropped 15.9% to $3.22 due to profitability pressures. The acquisition expanded product offerings and global reach in life sciences. Management completed integration while maintaining gross margins. Order backlog declined to $165.9M, though international segments showed improvement.
Kewaunee Scientific Corp reported fiscal 2026 results with revenue of $282M, downbeat net income of $10.47M and diluted EPS of $3.22, reflecting growth from acquisitions but pressure on profitability versus the prior year.
Financial Highlights
| Metric | Current year | Prior year | YoY change |
| Revenue¹ | $282M | $240.47M | 17.3% |
| Net income² | $10.47M | $11.58M | (9.7%) |
| Diluted EPS³ | $3.22 | $3.83 | (15.9%) |
¹ Reported as “Net sales”. ² Reported as “Net earnings”. ³ Reported as “Diluted earnings per share attributable to Kewaunee Scientific Corporation stockholders”.
Business Highlights
- Revenue growth was driven largely by the November 2024 acquisition of Nu Aire, which broadened Kewaunee’s product portfolio and distribution.
- Acquisition expanded channels and geographic reach, strengthening presence in life sciences, healthcare and in markets including India, Asia and Africa.
- Nu Aire added products such as biosafety cabinets, incubators and ultralow freezers, enhancing lab solutions and brand momentum.
- Management completed integration efforts and invested in corporate scaling while maintaining consistent gross margins amid higher sales.
- Order backlog declined to $165.9M; international backlog improved with India project deliveries, but overall timing of project execution remains variable.
Original SEC Filing: KEWAUNEE SCIENTIFIC CORP /DE/ [ KEQU ] - 10-K - Jun. 26, 2026